tiprankstipranks
Trending News
More News >
Symbio Pharmaceuticals Limited (JP:4582)
:4582
Japanese Market
Advertisement

Symbio Pharmaceuticals Limited (4582) Revenue

Compare
1 Followers

Symbio Pharmaceuticals Limited Revenue

Symbio Pharmaceuticals Limited had a revenue of 554.54M in the quarter ending Dec 31, 2024, with -9.68%. This bring the company's revenue in the last twelve months to 2.45B, Increased -20.02%. In the fiscal year ending Dec 31, 2024, Symbio Pharmaceuticals Limited had annual revenue of 2.45B with -56.12% growth.
Revenue (ttm)
2.45B
Revenue Growth
-56.12%
P/S Ratio
3.42
Revenue/Employee
¥22,712,148
Employees
108
Market Cap
¥8.38B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.45B-3.14B-56.12%
Dec 31, 2023
5.59B-4.42B-44.15%
Dec 31, 2022
10.01B1.76B+21.28%
Dec 31, 2021
8.25B5.27B+176.28%
Dec 31, 2020
2.99B149.30M+5.26%
Dec 31, 2019
2.84B-997.78M-26.01%
Dec 31, 2018
3.84B391.32M+11.36%
Dec 31, 2017
3.44B1.08B+45.44%
Dec 31, 2016
2.37B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis